News, Uncategorized

Big Pharma Roadblocks Hinder Integrative Cancer Treatment

Conventional Medicine is Not the Answer
Conventional Medicine is Not the Answer

One of the things that makes cancer so difficult to treat is its ability to adapt. Recurrence is not uncommon when standard cancer treatment methods, particularly chemotherapy, are used. As explained in our previous post, cancer cells have an uncanny ability to develop a resistance to chemotherapy drugs which can allow cancer to return.

Value of Integrative Treatment

Cancer researchers are finally coming to the conclusion reached decades ago by renowned German cancer specialist Dr. Josef Issels, the founder of Issels Integrative Oncology: Treating cancer effectively requires an integrative approach that combines multiple treatment protocols. Ridding the body of cancer and driving it into long-term remission requires a multi-pronged attack that must be individualized to meet the specific needs of each patient.

Big Pharma Roadblocks

While alternative cancer treatment centers offer numerous beneficial integrative cancer therapies, Western medicine’s current approach to integrative cancer treatment is heavily drug based. Not only is the approach limiting; but, as Dr. Carlos Moreno of Emory University recently criticized on Reuters.com, Big Pharma roadblocks are hindering the development of integrative drug therapies.

Profits vs. Patients

Combining drugs into “cancer cocktails” and treating cancer with drugs approved to treat other conditions has shown early promise. But these approaches require cooperation from drug companies, most of which have so far been unwilling to put patients ahead of profits, Moreno complains.

Issels Puts Patients First

As Moreno points out, cancer patients don’t have time to wait for researchers and drug companies to resolve their differences. Integrative immunotherapy offers an immediate and effective alternative. Issels non-toxic cancer vaccine program is not forced to rely on the largesse of drug companies. Our autologous cancer vaccines are prepared from the patient’s own blood to enhance the body’s natural ability to fight cancer. Visit our website to learn more about integrative immunotherapy.

Alternative Cancer Treatment, News

Big Pharma Criticized for Standing in the Way of New Cancer Treatments

Big Pharmasudical Problems
Big Pharmasudical Problems

“It is time for drug companies to put helping patients first,” says Dr. Carlos S. Moreno. The Associate Professor of Pathology and Laboratory Medicine and Biomedical Informatics at Emory University makes a compelling argument on Reuters.com that it’s time large pharmaceutical companies started living up to their stated goal of saving and improving lives. By placing their responsibilities to their shareholders and profit margin over their moral responsibility to better patients’ lives, Moreno says Big Pharma is holding back vital cancer research.

At issue are the roadblocks cancer researchers are encountering as they explore new avenues for treating cancer. As Moreno notes, “Researchers … are making remarkable discoveries to help identify new drugs and drug targets for cancer patients. Many new compounds are under investigation, including those that inhibit the growth of cancer cells, block the blood supply to tumors and prevent tumors from evading the immune system.”

The sequencing of cancer genomes has allowed the development of advanced targeted therapies and is providing researchers with new insights into how cancer grows and why it returns. As Moreno explains:

“One clear insight we have gained is the likelihood that no single drug will be able to defeat cancer. The reason most cancers become drug resistant and come back is because the DNA mutates quickly. Cancer cells that are not killed by the drugs survive, continue to grow and replace the cells that have been wiped out.”

Many cancer researchers have concluded that an integrative approach to cancer treatment is necessary to defeat cancer’s ability to mutate and survive. Unfortunately, researchers are finding that their ability to turn new discoveries into therapeutic cancer treatments is being stymied by Big Pharma’s constant eye on profit margins.

To be continued

Alternative Cancer Treatment, Cancer Research

Lung Cancer – A Quick Insight

Lung Cancer Treatment
Lung Cancer Treatment

The longstanding controversy regarding cigarettes and second-hand smoke has raised awareness of lung cancer. But how much do you really know about it? Learning some of facts about this disease can result in quicker recognition and more timely treatment.

Lung cancer is the second most common type for both sexes, behind only prostate cancer for men and breast cancer for women. However, it is the leading cause of deaths from cancer, accounting for approximately 27 percent of the overall total. The American Cancer Society estimates that 2014 will see nearly 225,000 new cases of lung cancer, split nearly 50/50 between men and women.

There are two main categories of lung cancer. Small cell, named after their appearance under a microscope, accounts for 10 to 15 percent of all cases and occurs primarily in heavy smokers. The other 85 to 90 percent of cases are non-small cell, which includes a variety of types that behave in similar ways.

While smoking is the major cause of lung cancer, it’s by no means the only one. Another factor that’s gained a great deal of attention is asbestos. Workers who inhale asbestos are at greater risk for lung cancer, including a rare type called mesothelioma. Long-term exposure to radon or diesel exhaust are other risk factors.

Integrated immunotherapy treatment offered at Issels alternative cancer treatment centers provides a natural, non-invasive option for patients suffering from lung cancer. Get a personalized course of treatment that helps maintain quality of life. Please visit our website for more information.

Alternative Cancer Treatment, Living with Cancer, Stress Management

Pet Therapy – Improving Your Quality of Life

Pet Therapy
Pet Therapy

Is there anything more adorable and heart-warming than a four-legged friend who offers unconditional love? Pet therapy has become an increasingly popular means of providing physical and emotional support for cancer patients and others dealing with serious health problems. Mayo Clinic oncologist Dr. Edward Creagan has referred to it as “medication without side effects”.

Sigmund Freud was known to use dogs as relaxation aides for his psychotherapy patients, but it’s only fairly recently that pets have been used to “treat” those suffering from cancer. Therapy Dogs International and Pet Partners, the two earliest animal-assisted therapy groups, date back to the mid-1970s.

Cancer patients who receive visit from therapy pets have demonstrated emotional benefits such as lowered stress levels and improved moods. Interacting with the pets can help relieve the loneliness and isolation that often accompanies medical treatment. Some patients have even demonstrated a reduced need for pain medication.

While pets have been known as good companions since the dawn of mankind, researchers have tried to find the specific reasons that pet therapy has proven to be so effective. Studies have shown that visits with pets can reduce the levels of cortisol in the bloodstream. Cortisol is a hormone that produces the “fight or flight” response during high-stress situations. In addition, it can raise the level of endorphins, which are the body’s natural pain-relieving hormones.

Pet therapy can provide a valuable boost to your quality of life during cancer treatment. It’s a good complement to the integrative approach used at Issels alternative cancer treatment centers. Please contact us for more information.

Alternative Cancer Treatment, Cancer Research

Patients Respond to Benefits of Integrative Cancer Therapy

Alternative Cancer Treatments are Worth a Try
Alternative Cancer Treatments are Worth a Try

It is unfortunate that Richard Howard did not discover the benefits of integrative cancer therapy until the final year of his 10-year battle with cancer. His family credits integrative therapies with the gains that allowed him to remain with his family a while longer and the increased feelings of comfort and well-being he experienced during his final year.

There is no way to know if Mr. Howard’s outcome would have been different had he embraced integrative cancer therapy sooner or obtained treatment at an experienced Center for Integrative Medicine rather than a local pilot program. What we do know is that over our more than 60-year history practicing integrative immunotherapy Issels Integrative Oncology has helped many cancer patients achieve complete long-term remission of advanced cancers and cancers that have proven resistant to standard treatment.

Mr. Howard’s daughter Sara, who encouraged her father to try integrative therapies, told the Litchfield (Connecticut) County Times, “I was like, ‘Dad, why not just try it?’ … I researched it and saw all the beneficial things it could do. He did and it was like, ‘Wow!’ and opening up this door for him to a whole other side of medicine.”

An engineer, Mr. Howard was at first skeptical of integrative therapies but was quickly won over by the increased comfort, sense of well-being and mobility he experienced following his first few alternative cancer therapies. The pilot program Mr. Howard participated in was limited to the integration of several Eastern medicine techniques such as acupuncture and massage; but a fully-developed, comprehensive integrative immunotherapy program can offer cancer patients a plethora of beneficial alternative cancer treatment options designed to support and enhance each other.

At Issels Integrative Oncology, we turn skeptics into believers every day. Click to hear what our patients have to say.

Alternative Cancer Treatment, Cancer Care Tips

Melanoma Treatment Breakthrough with Immunotherapy

A Break Trough in Immunotherapy
A Break Trough in Immunotherapy

Immunotherapy continues to prove itself an effective weapon in the fight against cancer. Recent studies show that treatment can produce lasting remission in patients suffering with melanoma, the deadliest form of skin cancer.

Leading pharmaceutical company Bristol-Myers Squibb conducted testing of nivolumab, a member of a new class of immunotherapies. Its purpose is to disable a protein called PD-1 which restricts the body’s own immune system from attacking cancer cells.

Phase 1 of the trial involved 107 advanced melanoma patients whose cancer had spread to other areas despite treatment with traditional drugs. These patients received nivolumab via intravenous infusions during alternating weeks for periods of up to 96 weeks.

Median life expectancy for people with advanced melanoma is one year. Follow-up studies after treatment with the nivolumab found that 62 percent of the patients were alive, with 43 percent surviving after two years. Researchers are encouraged by the fact that the immunotherapy continued to show positive results even after treatment concluded. The data also suggests that therapy during earlier stages can be even more effective.

Bristol-Myers is continuing Phase 3 trials with nivolumab that focus on other forms of cancer such as lung and kidney cancer. In some cases, testing is using a combination therapy including ipilimumab, another of the new immunotherapies that works on disabling a different cell receptor.

Issels natural cancer treatment is based on more than 60 years of successful experience using integrative immunotherapy. Patients receive personalized protocols created to address their unique needs. Please contact us to learn more about our treatment centers and programs.

Individualized Cancer Treatment